Pantoprazol Abz (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Abz, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children. GNH USA supplies Pantoprazol Abz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazol Abz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Abz is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates mucosal healing and reduces further erosion. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumours. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Helicobacter pylori eradication regimens (as adjunct): enhances the effectiveness of antibiotic combinations used to eradicate H. pylori.

Pantoprazol Abz may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: watery stools without blood. - Nausea: occasional feeling of stomach upset. - Abdominal pain: cramp‑like discomfort. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent diarrhoea with abdominal pain. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: abnormal liver function tests. - Acute interstitial nephritis: kidney inflammation presenting with fever and urinary changes.

Before starting Pantoprazol Abz, consider the following precautions: - Assess renal function: dosage adjustment may be required in severe impairment. - Review liver health: monitor if hepatic disease is present. - Evaluate need for long‑term therapy: prolonged use may increase fracture risk. - Monitor magnesium levels: especially in patients on diuretics or prolonged therapy. - Avoid abrupt discontinuation: taper to reduce rebound acid hypersecretion. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Abz can affect the absorption or metabolism of several medicines.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation. - Methotrexate (high dose): reduced renal clearance, watch for toxicity. - Digoxin: possible increase in serum levels. - Clopidogrel: reduced activation, assess antiplatelet effect. - Oral contraceptives: may lower efficacy, consider alternative contraception.